EphA4 agonist compound 23
EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases[1].
Product Specifications
UNSPSC
12352209
Target
Ephrin Receptor
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Neurological Disease
Smiles
O=C(N1CCC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCNC(N)=N)C(NC2=C(SC=C2C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CNC4=C3C=CC=C4)C(N[C@@H](CO)C(N5CCC[C@H]5C(N)=O)=O)=O)=O)=O)C)=O)=O)CC6=CC=C(C7=CC=CC=C7)C=C6)=O)C(C)C)=O)CCCC)=O)CC8=CC=C(O)C=C8)=O)CCN
Molecular Formula
C79H103N17O16S
Molecular Weight
1578.83
References & Citations
[1]Prentiss AM, et al. Constrained β-Hairpins Targeting the EphA4 Ligand Binding Domain. J Med Chem. 2024 Dec 26;67 (24) :22245-22253.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
